Dr. Benjamin Burke is a scientist who's research overlaps chemistry and biology by developing imaging agents for medical diagnosis. His work is focused on the chemical design of new drugs for cancer and heart imaging, with most of his work in radioactive drug design for imaging with the nuclear medicine technique Positron Emission Tomography (PET)
Experience
2013–present
Molecular Imaging Post-Doctoral Research Assistant, University of Hull
Education
2013
University of Hull, PhD
2010
University of Hull, BSc
Publications
2015
Probing the limits of tetraazamacrocycle-glyoxal condensates as bidentate ligands for Cu2+, Euro. J. Inorg. Chem
2015
o-Boronate and o-Trifluoroboratophenyl phosphonium salts supported by L-alpha-amino acid side chain, J. Org. Chem
2015
Chelator free gallium-68 radiolabelling of silica coated iron oxide nanorods via surface interactions, Nanoscale
2015
Boron-18F containing positron emission tomography radiotracers: Advances and Opportunities, Contrast Media Mol. Imaging
2014
Final step gallium-68 radiolabelling of silica coated iron oxide nanorods as potenetial PET/MR multimodal imaging agents, Faraday Discussions
2014
Recent advances in chelator design and labelling methodology for 68Ga radiopharmaceuticals, J. Labelled Comp. Radiopharm.
2014
A benzimidazole functionalised DO3A chelator showing pH switchable coordination modes with lanthanide ions, Dalton trans.
2013
New bifunctional chelators for Ga-68 complex formation, J. Labelled Comp. Radiopharm.
2013
Rapid synthesis of cross-bridged cyclam chelators for copper(II) complex formation, Comptes Rendus Chimie